Duke University Medical Center requests continuing support for its General Clinical Research Center. This center consists of a hospital inpatient ward, an outpatient clinic, a metabolic kitchen, a sample- processing core laboratory, and a research environment for controlled observation and timely collection of patient samples including blood, urine, and other specimens as needed. Use of any of the components of the center by a physician-investigator requires approval of the GCRC Scientific Advisory Committee and approval of the Institutional Review Board for Clinical Investigations. All Duke University medical Center faculty with hospital admitting privileges Are eligible to submit protocols to the Scientific Advisory Committee. The diversity of protocols is reflected in the variety of departments of the principal investigators, which include the Departments of Medicine, Obstetrics and Gynecology, Pediatrics, Psychiatry, Surgery, Radiation Oncology, Anesthesiology, and Engineering. There is substantial collaboration among clinician-investigators in the clinical departments and between GCRC investigators in clinical departments and complementary basic science departments. The GCRC is the site for training medical students, house officers, and post-doctoral fellows in the latest research methodology. Also included in this application are a description of accomplishments since the previous site visit, a complete center infrastructure to support somatic cell and gene therapy protocols, encouragement of the interdisciplinary nature of clinical research, and renovation of our current facilities. A major initiative of the past three years has been to facilitate and support the transition of somatic cell and gene therapy research efforts into clinical trials. The position of Laboratory Consultant was developed and, in collaboration with the Department of Surgery, a Cellular Core Laboratory established to provide a """"""""good laboratory practices"""""""" (GLP) environment for processing cells used in clinical trials. This initiative has been quite successful, as evidenced by the number of GCRC approved protocols and patients treated utilizing these novel therapies. With support of the GCRC, Duke University Medical Center investigators will continue to bring the latest advances in basic research to the beside in a multi disciplinary approach to the health and disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000030-41
Application #
6453578
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Cheung, Geoffrey P
Project Start
1975-10-01
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
41
Fiscal Year
2002
Total Cost
$3,429,552
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Adams, Rebecca N; Mosher, Catherine E; Blair, Cindy K et al. (2015) Cancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis. Cancer 121:77-83
Azrad, M; Vollmer, R T; Madden, J et al. (2015) Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial. Biotech Histochem 90:184-9

Showing the most recent 10 out of 128 publications